Abiopharma

Aardvark Therapeutics (AARD) Faces Investor Scrutiny Amid 56% Drop On Clinical Pause For Lead Drug Candidate- HBSS

Erasca, Inc. (ERAS) Faces Securities Class Action Amid Patient Death, Intellectual Property Questions, $2.8 Billion Market Cap Loss -- HBSS

Nasdaq Texas Convenes Inaugural Advisory Board to Strengthen Support for Texas Business Community

Vivakor Expands Annualized Contracted Revenue to Approximately $420 Million with New Cushing Crude Oil Transaction

Veritone, Inc. (VERI) Securities Class Action Filed After Admitting Improper Revenue Accounting - HBSS

Embecta Corp. (EMBC) Faces Securities Class Action for Allegedly Concealing Competitive Threats to Pen Needle Business -- HBSS

SS&C Black Diamond Wealth Solutions’ TAMP Exceeds USD 2 Billion in Assets

ZipRecruiter Announces Partial Repurchase of Senior Notes

JLL Announces Details of Second Quarter 2026 Earnings Release and Conference Call

Polestar strengthens its focus on Europe following decision under the U.S. Connected Vehicle Rule